Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 14,210 | 0 | 0 |
| Operating Income | -14,210 | N/A | N/A |
| Other Income | 552 | 0 | 0 |
| Pre-tax Income | -13,658 | 0 | 0 |
| Net Income Continuous | -13,658 | N/A | N/A |
| Net Income | $-13,658 | $N/A | $N/A |
| EPS Basic Total Ops | -35.47 | N/A | N/A |
| EPS Basic Continuous Ops | -35.48 | N/A | N/A |
| EPS Diluted Total Ops | -35.47 | N/A | N/A |
| EPS Diluted Continuous Ops | -35.48 | N/A | N/A |
| EBITDA(a) | $-13,691 | $N/A | $N/A |